q3 earnings per share $6.05.
sees fy adjusted earnings per share $26 to $28 from continuing operations.
q3 adjusted earnings per share $6.82.
q3 revenue rose 4.3 percent to $4.1 billion.
sees 2021 base business growth of 18.5% to 19.5% and covid testing down 11% to up 6%.
sees fy 2021 diagnostics revenue up 8% to 10%.
sees fy 2021 base business revenue growth of 21.5% to 22.5%.
compname reports 114,000 tests per day in september, with volumes declining week-over-week since that time.